(Q70590742)
Statements
Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer (English)
M Kaufmann
W Jonat
U Abel
J Hilfrich
H Caffier
R Kreienberg
G Trams
K Brunnert
J Schermann